Trial Profile
Prevention of Stress Hyperglycemia With the Use of DPP-4 Inhibitors in Non-diabetic Patients Undergoing Non-cardiac Surgery, a Pilot Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary) ; Insulin aspart; Insulin detemir; Insulin glargine; Insulin lispro
- Indications Hyperglycaemia
- Focus Therapeutic Use
- 11 Jan 2018 Status changed from recruiting to completed.
- 28 Jun 2016 Status changed from not yet recruiting to recruiting.
- 21 May 2016 Planned initiation date changed from 1 Apr 2016 to 1 May 2016.